Hepatitis B core protein allosteric modulators
US10183936B2 · kind B2 · utility
2Cited by
4References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 13, 2015 |
| Grant date | Jan 22, 2019 |
| Priority date | — |
| Expiry date | Mar 13, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.